Cargando…
Corneal Endothelial-like Cells Derived from Induced Pluripotent Stem Cells for Cell Therapy
Corneal endothelial dysfunction is one of the leading causes of corneal blindness, and the current conventional treatment option is corneal transplantation using a cadaveric donor cornea. However, there is a global shortage of suitable donor graft material, necessitating the exploration of novel the...
Autores principales: | Ng, Xiao Yu, Peh, Gary S. L., Yam, Gary Hin-Fai, Tay, Hwee Goon, Mehta, Jodhbir S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418878/ https://www.ncbi.nlm.nih.gov/pubmed/37569804 http://dx.doi.org/10.3390/ijms241512433 |
Ejemplares similares
-
Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors
por: Bandeira, Francisco, et al.
Publicado: (2020) -
Regenerative capacity of the corneal transition zone for endothelial cell therapy
por: Sie, Nicole Ming, et al.
Publicado: (2020) -
Regulation of Oxidative Stress in Corneal Endothelial Cells by Prdx6
por: Lovatt, Matthew, et al.
Publicado: (2018) -
Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases
por: Mansoor, Hassan, et al.
Publicado: (2019) -
Prospects and Challenges of Translational Corneal Bioprinting
por: Fuest, Matthias, et al.
Publicado: (2020)